
Fibroblast growth factor 21 serum concentrations in patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (DM2).
Walus-miarka, M., Idzior-Walus, B., Kapusta, M., Trojak, A., Miarka, P., Malecki, M.T.Volume:
275
Langue:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2018.06.449
Date:
August, 2018
Fichier:
PDF, 46 KB
english, 2018